Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?
Luis A. Kluth(Goethe University Frankfurt), Shahrokh F. Shariat(Universitätszahnklinik Wien), Markus Graefen(Eppendorf (Germany)), Évanguelos Xylinas(NewYork–Presbyterian Hospital), Andreas Becker(Goethe University Frankfurt), Mesut Remzi(Landesklinikum Korneuburg), Christian Seitz(Medical University of Vienna), Alberto Briganti(University College London Hospitals NHS Foundation Trust), Yair Lotan(Southwestern Medical Center), Douglas S. Scherr(Cornell University), Morgan Rouprêt(Sorbonne Université), Ashutosh Tewari(Icahn School of Medicine at Mount Sinai), Paul Schramek(Krankenhaus Barmherzige Brüder), Harun Fajković(University of Applied Sciences St Pölten), Wolfgang Loidl(Ordensklinikum Linz Barmherzige Schwestern), Malte Rieken(NewYork–Presbyterian Hospital), Pierre I. Karakiewicz(Université de Montréal), Michael Herman(Borland Groover Clinic), Bertrand Guillonneau(Groupe Hospitalier Diaconesses Croix Saint-Simon), Niccolò Passoni(Vita-Salute San Raffaele University), Felix K.‐H. Chun(Universität Hamburg)
Urologic Oncology Seminars and Original Investigations
September 18, 2013
Cited by 10
Related Papers
EAU Guidelines on Interventional Treatment for Urolithiasis
|European Urology|2015|1.8k
EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis
|European Urology|2015|940
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: EAU Guidelines
|European Urology|2014|410